ctrl K

Price Alert

CERo Therapeutics Inc. (CERO)

NASDAQ: CERO · Real-Time Price · USD

8.32

-0.11 (-1.25%)

At close: Aug 21, 2025, 11:20 AM

CERo Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.33M	96.87K	42.14M	1.1M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	178.5M
Other Long-Term Assets	500K	n/a	n/a	200.65K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	386.98K	8.44M	225.19K	262.5K
Total Current Assets	3.71M	1.97M	42.37M	1.36M
Property-Plant & Equipment	1.99M	3.16M	4.27M	4.65M
Goodwill & Intangibles	n/a	n/a	n/a	-4.65M
Total Long-Term Assets	2.49M	3.16M	4.27M	178.72M
Total Assets	6.21M	5.13M	42.37M	180.08M
Account Payables	4.51M	3.54M	391.19K	14.43K
Deferred Revenue	n/a	n/a	207.97K	-1.05M
Short-Term Debt	876.39K	1.55M	650K	n/a
Other Current Liabilities	428.25K	23.63K	28.44M	54.86K
Total Current Liabilities	7.4M	5.17M	30.75M	98.07K
Long-Term Debt	n/a	n/a	n/a	3.02M
Other Long-Term Liabilities	n/a	17.59M	6.81M	6.13M
Total Long-Term Liabilities	699.11K	17.59M	9.15M	9.15M
Total Liabilities	8.1M	22.76M	39.9M	9.25M
Total Debt	1.58M	1.55M	650K	3.6M
Common Stock	242.00	547.00	13.22M	178.5M
Retained Earnings	-70.92M	-14.2M	-10.76M	-7.67M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	-1.89M	-14.2M	2.47M	170.83M
Total Investments	n/a	8.44M	n/a	178.5M